• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metformin does not improve survival of cholangiocarcinoma patients with diabetes.

作者信息

Yang Zhen, Zhang Xiaodan, Roberts Rosebud O, Roberts Lewis R, Chaiteerakij Roongruedee

机构信息

Division of Gastroenterology and Hepatology.

Department of Infectious Diseases, Shandong Provincial Hospital affiliated with Shandong University, Jinan, Shandong, China.

出版信息

Hepatology. 2016 Feb;63(2):667-8. doi: 10.1002/hep.27821. Epub 2015 May 7.

DOI:10.1002/hep.27821
PMID:25833233
Abstract
摘要

相似文献

1
Metformin does not improve survival of cholangiocarcinoma patients with diabetes.二甲双胍不能提高胆管癌合并糖尿病患者的生存率。
Hepatology. 2016 Feb;63(2):667-8. doi: 10.1002/hep.27821. Epub 2015 May 7.
2
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.二甲双胍和维生素 D 对胆管癌患者临床结局的影响。
Oncology. 2021;99(5):292-299. doi: 10.1159/000512796. Epub 2021 Feb 24.
3
[New clinical data with metformin therapy in patients with diabetes mellitus].[二甲双胍治疗糖尿病患者的新临床数据]
Orv Hetil. 2010 Dec 5;151(49):2025-30. doi: 10.1556/OH.2010.29005.
4
Benefits of Metformin Use for Cholangiocarcinoma.使用二甲双胍治疗胆管癌的益处。
Asian Pac J Cancer Prev. 2015;16(18):8079-83. doi: 10.7314/apjcp.2015.16.18.8079.
5
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.肝内胆管癌的风险因素：二甲双胍的使用与降低癌症风险之间的关联。
Hepatology. 2013 Feb;57(2):648-55. doi: 10.1002/hep.26092. Epub 2012 Dec 12.
6
Metformin and pancreatic cancer: a clue requiring investigation.二甲双胍与胰腺癌：有待探究的线索。
Clin Cancer Res. 2012 May 15;18(10):2723-5. doi: 10.1158/1078-0432.CCR-12-0694. Epub 2012 Mar 31.
7
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis.二甲双胍对糖尿病患者胆管癌发病率的影响：一项系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2023 Mar 1;35(3):241-247. doi: 10.1097/MEG.0000000000002503. Epub 2022 Dec 23.
8
[Analysis of survival and factors affecting the survival after surgical resection of peripheral cholangiocarcinoma: 318 cases in single institute].
Korean J Hepatol. 2007 Jun;13(2):208-21.
9
Place of surgery in opisthorchiasis associated cholangiocarcinoma.华支睾吸虫病相关胆管癌的手术部位
Southeast Asian J Trop Med Public Health. 1997;28 Suppl 1:85-90.
10
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.二甲双胍对合并糖尿病的结直肠癌患者生存的影响。
Int J Cancer. 2012 Aug 1;131(3):752-9. doi: 10.1002/ijc.26421. Epub 2011 Oct 20.

引用本文的文献

1
Advance of Metformin in Liver Disease.二甲双胍在肝病治疗中的进展
Curr Med Chem. 2024 Jan 30. doi: 10.2174/0109298673274268231215110330.
2
The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials.二甲双胍的功能、机制和临床应用：有潜力的药物，无限的潜力。
Arch Pharm Res. 2023 May;46(5):389-407. doi: 10.1007/s12272-023-01445-2. Epub 2023 Mar 24.
3
Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis.二甲双胍对胆道癌风险和预后的影响：系统评价和荟萃分析。
Medicina (Kaunas). 2023 Feb 6;59(2):298. doi: 10.3390/medicina59020298.
4
Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China.二甲双胍在晚期肝外胆管癌患者中的应用与生存情况：中国阜阳的一项单中心队列研究
Gastroenterol Res Pract. 2021 Oct 29;2021:9468227. doi: 10.1155/2021/9468227. eCollection 2021.
5
Repurposing metformin for the treatment of gastrointestinal cancer.重新利用二甲双胍治疗胃肠道癌症。
World J Gastroenterol. 2021 May 7;27(17):1883-1904. doi: 10.3748/wjg.v27.i17.1883.
6
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells.二甲双胍在人原发性肝内胆管癌细胞中发挥抗癌作用并逆转上皮间质转化特征。
Sci Rep. 2021 Jan 28;11(1):2557. doi: 10.1038/s41598-021-81172-0.
7
Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes.2型糖尿病患者中的二甲双胍与胆道癌
Front Oncol. 2020 Oct 27;10:587666. doi: 10.3389/fonc.2020.587666. eCollection 2020.
8
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives.人类胆管细胞癌代谢可塑性的多方面：当前观点概述。
Cells. 2020 Mar 3;9(3):596. doi: 10.3390/cells9030596.
9
Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.二甲双胍增强三氧化二砷抑制肝内胆管癌的作用：p38丝裂原活化蛋白激酶、ERK3和雷帕霉素靶蛋白复合物1的作用
J Hematol Oncol. 2017 Feb 28;10(1):59. doi: 10.1186/s13045-017-0424-0.
10
Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.二甲双胍的使用可提高糖尿病肝癌患者的生存率：系统评价与荟萃分析。
Oncotarget. 2016 Oct 4;7(40):66202-66211. doi: 10.18632/oncotarget.11033.